Komori
Takagi Seiko (4242) · InitiativeRestated

Industry-Academia Collaborative Research in Regenerative Medicine

First written in FY2023. 1 of 2 entries say "Restated". Latest entry: FY2024.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023 – FY20242023: 120232024: 12024
Same theme, other companies
Industry-Academia Collaborative Research in Regenerative MedicineA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「また、再生医療分野では産学連携による研究開発を推進しております。」

    再生医療分野での産学連携研究を継続している。
  2. FY2023First statedAnnual report

    「また、再生医療分野では産学連携による研究開発を推進しております。」

    従来の医療機器部品・針無し注射器とは別に、再生医療分野での産学連携研究を初めて明示している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Takagi Seiko yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Industry-Academia Collaborative Research in Regenerative Medicine | TAKAGI SEIKO CORPORATION (4242) | Komori